Paul T. Quinlan
General Counsel & SecretaryMr. Paul T. Quinlan served as General Counsel, Chief Compliance Officer and Corporate Secretary at CymaBay Therapeutics, Inc. since October 2020 until March 2024. He is General Counsel of Oruka Therapeutics, Inc since August 29, 2024 and serves as its Secretary since August 29, 2024. He had been General Counsel and Secretary of Cymabay Therapeutics, Inc. since December 2017 until February 02, 2020. Mr. Quinlan served as Secretary and General Counsel of TerraVia Holdings, Inc. since June 2010 and May 2010 respectively until January 2018. Mr. Quinlan served as the Chief Legal Officer at TerraVia Holdings, Inc. since January 2016. Mr. Quinlan served as Senior vice President at TerraVia Holdings, Inc. Mr. Quinlan has more than a decade of legal, regulatory and business experience, as well as substantial biotech experience, which includes strategic collaborations and licensing. From 2000 to 2005, Mr. Quinlan held various positions in the legal department at Maxygen, Inc. He most recently served as Chief Corporate Securities Counsel at the biotechnology company Maxygen, Inc. Mr. Quinlan was responsible for all securities law, compliance and general corporate legal work, including SEC reporting and compliance, securities registration, corporate governance and mergers and acquisition. He also helped negotiate and draft key strategic collaboration and licensing agreements. Earlier in his career he worked as an Associate at the law firms of Cooley Godward LLP and Cravath Swaine & Moore LLP. He received his Master of Laws from Columbia University School of Law in New York and his Bachelor of Laws from Queen's University in Kingston, Ontario. He Earned a Master of Science in Medical Biophysics and a Bachelor of Science Degree from the University of Toronto.
Positions
- Company NameOruka Therapeutics, Inc.Stock CodeORKAPositionGeneral Counsel & SecretaryColleagues
- LOLawrence Otto KleinPresident, CEO & Director
- SKSamarth KulkarniIndependent Chairman of Board
- JGJoana GoncalvesChief Medical Officer
- AAArjun AgarwalSenior VP of Finance & Treasurer
- LSLaura SandlerChief Operating Officer
- KMKristine M. BallIndependent Director
- PEPeter Evan HarwinIndependent Director
- ABAndrew BlauveltChairman of Scientific Advisory Board
